
Europe's Hepatitis a Outbreak: What You Need to Know
Last week, the European Centre for Disease Prevention and Control (ECDC) issued an alert warning of a multicountry outbreak of hepatitis A virus (HAV) infections. Two closely related virus strains have been identified across affected regions, with outbreak spikes centered in Austria, Czechia, Hungary, and Slovakia.
The spread appears to be via ongoing person-to-person transmission within connected social networks or geographical areas, according to genetic sequencing. While Germany is not considered an affected country, it has identified three cases with genomic profiles matching those in Hungary and Austria.
Cross-Border Transmission
The ECDC said testing confirmed cross-border transmission and recommended that EU/European Economic Area public health authorities undertake epidemiologic investigations, targeted prevention measures, and community-based outreach to contain the outbreak and protect public health.
In total, the four countries in the outbreak have reported 2097 cases of hepatitis A since the start of the year: 880 in Slovakia, 87 in Austria, 600 in Czechia, and 530 in Hungary. The disease has proved fatal in three cases in Austria and six in Czechia.
Transmission Routes
The ECDC also issued a rapid risk assessment summarizing that HAV is transmitted primarily via contaminated food, water, or close contact with infected individuals. Risk factors include poor sanitation, lack of access to safe water, inadequate access to basic hygiene, close contact with infected individuals, particularly during risky sexual behaviors such as anogenital-oral sex, use of recreational drugs, and travel to endemic areas. The likelihood of developing symptomatic or severe hepatitis A increases with age and is higher among people who are immunosuppressed or have chronic liver disease.
The current outbreak is primarily affecting homeless adults, people who use or inject drugs, and those living in poor sanitary conditions or with limited access to healthcare. Additionally, cases have been reported among members of the Roma communities in both Czechia and Slovakia.
Age Differences
The strains detected all involved two closely related HAV subgenotype IB variants. However, there are demographic differences between affected populations in different countries. Reported cases in Hungary were mainly in adults, whereas in Czechia the most affected age groups were young children aged 1-9 years and young adults aged 25-44 years.
In Slovakia, where the outbreak has been ongoing since the end of 2022 and case numbers are now falling, cases were reported especially in Roma communities in eastern Slovakia and involved mainly children. However, the current epidemiologic pattern marks a notable shift from previous years, the ECDC said. Although 47% of the 2025 cases have occurred within Roma communities, an additional 20% involve adults who are homeless and/or use or inject drugs. Several smaller clusters have also been reported in young children attending preschool facilities.
In Austria, case numbers are still increasing — the number reported for the first 5 months of 2025 already exceeds the total recorded in 2024. There was a male predominance (68%), patients' ages ranged from 3 to 84 years (median of 34 years), 63% of cases for which information was available required hospitalization, and three deaths have been reported.
What Clinicians Should Know
Kinga Kardics, MD
To find out what frontline clinicians might need to know about the hepatitis A outbreak, Medscape Medical News spoke with Kinga Kardics, MD, a tropical disease specialist at the Pediatric Center at Semmelweis University, Budapest, Hungary. She said the center was seeing one to three patients a week with HAV infections.
How Is the Virus Transmitted?
The virus can be transmitted through contaminated water, food, and via the fecal-oral route among close contacts: household members, sexual contacts, and children attending day care centers or schools. Among pediatric patients in Hungary, the main transmission route has been the fecal-oral route in schools and nurseries, she said.
Who Is at Risk?
Kardics noted that additional risk factors or risk groups that have been associated with the illness in outbreaks include men having sex with men, children with immunodeficiencies, pregnant women, and patients with chronic liver diseases.
What Symptoms Should Alert Physicians?
Most patients with HAV infection have few or mild symptoms, Kardics said. Usual signs are fatigue, nausea, loose stools, fever that lasts just for a few days, and jaundice.
Most of the pediatric patients seen at her center have been asymptomatic or had only mild symptoms. In teenagers, the onset of the illness is usually abrupt, with fever, malaise, and abdominal discomfort. Jaundice is the predominant symptom.
What Is the Course of Disease?
Most patients recover spontaneously, are in good condition, and can stay at home until recovery, she said, though some patients need intravenous fluid replacement for dehydration. So far this year, the center at Semmelweis University has hospitalized about 10 children with hepatitis A infection. All of them recovered, no chronic infection has been detected, and no hepatitis A-related death has been reported so far in the pediatric population.
What Basic Hygiene Precautions Should Be Advised in the Community?
Practicing good hand hygiene can prevent the spread of HAV, Kardics said. People in the community should be advised to undertake frequent and thorough handwashing with soap and water, particularly after using the bathroom, after changing diapers, and before preparing or eating food.
What Should People in At-Risk Groups Do to Protect Themselves?
Strict control measures, such as reinforcing personal hygiene, contact tracing, and administration of vaccine to exposed persons, have proven to be effective in outbreaks, Kardics said. Populations with a higher risk for serious disease from HAV infection should consider vaccination. Several inactivated vaccines are available for prevention, all showing very high efficacy. Active (antigen) immunization is also available in Hungary and is effective if administered within 2 weeks of exposure.
Prophylactic Measures
The ECDC has advised that physicians in all countries should consider targeted vaccination of population groups most likely to be exposed to the virus. Post-exposure prophylaxis using the hepatitis A vaccine should be prioritized for close contacts of identified cases according to national guidelines.
Epidemiologic investigation of the outbreak is continuing.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Glaukos gains EU certification for iStent infinite and other MIGS devices
Glaukos has secured European Union Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other micro-invasive glaucoma surgery (MIGS) technologies, including the iStent inject W. According to the company, its iStent trabecular micro-bypass stenting platform predominantly involves the insertion of micro-scale surgical devices intended to minimise intraocular pressure (IOP) with the restoration of pathways of the natural aqueous humor outflow for individuals with glaucoma. Known for creating two patent bypass pathways via the trabecular meshwork, the iStent inject W claims to be one of the smallest medical devices to be implanted in the body of a human. Its design allows for multi-directional flow through Schlemm's canal, offering a micro-invasive approach to glaucoma treatment. The iStent infinite Trabecular Micro-Bypass System Model iS3 is intended to minimise IOP in adults with primary open-angle glaucoma where prior treatments have failed. As the first standalone micro-invasive implantable alternative, the iStent infinite is said to have been tailored to maximise outflow with minimal disruption to natural anatomy, occupying 3% of Schlemm's canal. Glaukos CEO and chairman Thomas Burns said: "We are pleased to receive these important regulatory clearances for our leading trabecular micro-bypass stenting devices, marking our company's first approvals under the new EU regulatory framework. 'These important milestones will not only help us maintain and grow our presence in Europe but also advance and accelerate our broader Interventional Glaucoma initiatives globally. We are eager to commence commercial launch activities for these novel MIGS therapies over the coming months." Last year, the company began commercial launch activities for iDose TR, an intracameral procedural pharmaceutical that provides continuous glaucoma drug therapy inside the eye for extended periods. In 2023, speciality materials and chemical company Celanese entered an agreement with Glaukos for the supply of its VitalDose drug delivery platform. "Glaukos gains EU certification for iStent infinite and other MIGS devices" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
11 hours ago
- Yahoo
Protecting children online: The time to act is now
In today's digital era, children are growing up in a world where social media are as integral to their daily lives as school or family. While technology offers tremendous opportunities for learning, creativity, and connection, it also exposes young people to significant risks that can no longer be overlooked. The consequences are deeply concerning. According to a 2023 report by the European Commission, one in three young people in the EU spends more than three hours per day on social media. This level of overexposure has been closely associated with a growing mental health issues among minors—including anxiety, depression, and low self-esteem. A 2024 study by the World Health Organisation showed that a problematic social media use among adolescents increased from 7% in 2018 to 11% in 2022. It highlights negative impacts on mental health, sleep, well-being and academic performance. Social media platforms – often built around addictive algorithms – are designed to keep young users engaged for extended periods. Constant exposure to idealised, curated content can distort self-perception, fuelling feelings of inadequacy and dissatisfaction. These are not just statistics—they reflect the genuine emotional and psychological struggles faced by an entire generation that is increasingly ill–equipped to navigate the digital world in a healthy and balanced manner. Europe has made notable progress through initiatives like the Better Internet for Kids (BIK+) strategy and the Digital Services Act (DSA). Yet, the current framework remains insufficient. The online protection of children must be elevated to a political and societal priority, underpinned by concrete and enforceable action. We must therefore move swiftly to implement a set of focused measures, starting with default privacy settings for children's accounts to reduce the risk of unsolicited contact from strangers. We also asking for ecalibrated recommender systems that prioritise explicit user feedback—such as deliberate selection of topics—to minimise the risk of children being drawn into harmful content rabbit holes. We want enhanced safety controls, including the ability for children to block or mute any user and protection from being added to group chats without their explicit consent, thereby reducing exposure to cyberbullying. Above all, mandatory age verification mechanisms must be implemented across all social networks. Such measures are essential to prevent minors from bypassing age restrictions and to substantially reduce their exposure to harmful online environments. The European Commission's recent draft guidelines on the protection of minors under the DSA mark a significant step towards a safer digital space. They offer a unique opportunity to establish age verification a a standard practice across social networks—not as an optional feature, but as a strict requirement. Enforcing age verification will equip platforms with the technical means necessary to uphold their own terms of service. It will also facilitate the enforcement of EU and national laws that set minimum age requirements for access to specific digital products or services. If we are genuinely committed to ensuring that the digital world fosters healthy development, learning, and meaningful connection—rather than becoming a breeding ground for anxiety, addiction and harm—then the decisive action must be taken now. Alexander Pröll, State Secretary for Digitalisation, Combating Antisemitism and Public Service, and the Constitution, Austria; Prof Radovan Fuchs, PhD., Minister of Science, Education and Youth, Croatia; Damir Habijan, Minister of Justice, Public Administration and Digital Transformation, Croatia; Dr Nicodemos Damianou, Deputy Minister of Research, Innovation and Digital Policy, Cyprus; Caroline Stage Olsen, Minister for Digital Affairs, Denmark; Clara Chappaz, Minister of Artificial intelligence and Digital Affairs, France; Elisabeth Borne, Minister of National Education, Higher Education and Research, France; Catherine Vautrin, Minister of Labour, Health, Solidarity, and Families, France; Karin Prien, Federal Minister of Education, Family Affairs, Senior Citizens, Women and Youth, Germany; Dimitrios Papastergiou, Minister of Digital Governance, Greece; Sofia Zacharaki, Minister of Education, Religious Affairs and Sports, Greece; Patrick O'Donovan, Minister for culture and communications, Ireland; Prof Giuseppe Valditar, Minister for Education and Merit, Italy; Alessio Butti, Undersecretary of State to the Presidency of the Council of Ministers, responsible for technological innovation and digital transition, Italy; Elisabeth Margue, Minister for Justice and Minister attached to the Prime Minister, responsible for the Media and Connectivity, Luxembourg; Claude Meisch, Minister for Education, Children and Youth Affairs, Luxembourg; Tomáš Drucker, Minister of Education, Research, Development, and Youth, Slovakia; Ksenija Klampfer, Minister of Digital Transformation, Slovenia; Vinko Logaj, Minister of Education and Care, Slovenia; Oscar López Águeda, Minister for Digital and Civil Service Transformation, Spain and María del Pilar Alegría Continente, Minister for Education and Vocational Training, Spain all coauthored this opinion article.


New York Post
a day ago
- New York Post
Deadly Hepatitis A outbreak infects thousands of travelers at popular European destinations
A spike in viral infections has sickened thousands of travelers and caused several deaths at some popular European destinations. Four countries — Austria, Czechia, Hungary and Slovakia — have reported a spike in hepatitis A cases between January and May 2025, according to a rapid risk assessment issued by the European Centre for Disease Prevention and Control (ECDC). In total, 2,097 cases have been reported across the four countries. Slovakia, which has been dealing with an active outbreak since 2022, represents 880 of those cases. Czechia is the next most affected country, reporting 600 cases and six deaths, the ECDC stated. Hungary has reported 530 cases in 2025, and Austria has reported 87. Hepatitis A is an 'acute viral liver disease' caused by the hepatitis A virus (HAV), according to the agency. 3 In total, 2,097 cases have been reported across the four countries. Getty Images/iStockphoto The disease is mainly spread through contaminated food or water, or through close contact with infected people. Dr. Marc Siegel, Fox News senior medical analyst, said that hepatitis A is a 'widely transmissible' disease that spreads easily among food handlers and 'can get you very sick.' People who have not received the hepatitis A vaccination or been infected by the virus are susceptible, the agency noted. Vaccinations are given in two doses, six to 12 months apart, according to Siegel. Every morning, the NY POSTcast offers a deep dive into the headlines with the Post's signature mix of politics, business, pop culture, true crime and everything in between. Subscribe here! 'People will have lifetime immunity after infection,' the doctor noted. 'A doctor can check your titres (levels of blood antibodies) to document that you are immune from prior vaccination.' Groups most affected by the infections include people who are homeless, use or inject recreational drugs or live in unsanitary conditions, as well as those with limited access to healthcare. 'Within these groups, the risk of the disease is assessed as moderate for those below 40 years of age and high for adults 40 years of age or older, as the severity of the disease increases with age,' the ECDC stated. 3 The disease is mainly spread through contaminated food or water, or through close contact with infected people. BSIP/Universal Images Group via Getty Images 'For people with predisposing liver disease or older adults, the risk can be very high. The risk for the broader population in these countries is assessed as low to moderate.' Those who are immunosuppressed are also at a higher risk, the alert said. Not everyone will develop symptoms, but those who do may notice the following common effects, according to the U.S. Centers for Disease Control and Prevention (CDC). Dark urine or clay-colored stools Diarrhea Fatigue Fever Joint pain Loss of appetite Nausea, stomach pain or vomiting Yellow skin or eyes (jaundice) 'This outbreak reminds us that hepatitis A can cause serious illness and death, especially among people with limited access to healthcare and basic hygiene,' said Ole Heuer, head of the ECDC's One Health Unit, in a press release. 3 Those who are immunosuppressed are also at a higher risk, the alert said. LightRocket via Getty Images 'We need to strengthen outreach, provide access to vaccination in groups more likely to be exposed and ensure basic sanitation, especially in response to the increase in cases.' To address the outbreak, the ECDC recommends investigating potential means of transmission of hepatitis A, such as 'possible foodborne transmission or spill-overs into other groups at increased risk of infection.' The agency also calls for targeted vaccination programs, 'post-exposure prophylaxis' to close contacts to prevent infection, and more genetic testing of the virus, as well as increased education and awareness among high-risk groups. According to the CDC, receiving the hepatitis A vaccine or immune globulin (medication containing antibodies) within two weeks of exposure can prevent illness.